Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Item

http://www.wikidata.org/entity/Q40655044

Q40655044

about

Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA Regulation of adult bone turnover by sex steroids Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system.Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice.Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation.Increased adipogenesis in cultured embryonic chondrocytes and in adult bone marrow of dominant negative Erg transgenic mice Titanium oral implants: surface characteristics, interface biology and clinical outcome.New insights, recent advances, and current challenges in the biological treatment of multiple myeloma.MicroRNAs Regulate Vascular Medial Calcification.Runx2-Smad signaling impacts the progression of tumor-induced bone disease Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.Homing of cancer cells to the bone Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors.Deletion of core-binding factor β (Cbfβ) in mesenchymal progenitor cells provides new insights into Cbfβ/Runxs complex function in cartilage and bone development Runx2 and dental development.MicroRNA control of bone formation and homeostasis.Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.RUNX2 Mutation Impairs 1α,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.NOTCHing the bone: insights into multi-functionality.Post-translational Regulation of Runx2 in Bone and Cartilage.Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.RUNX2 in mammary gland development and breast cancer.Transcriptomic network support distinct roles of classical and non-classical monocytes in human.Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.Runx Genes in Breast Cancer and the Mammary Lineage.Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation.Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.A Comparison of the Process of Remodeling of Hydroxyapatite/Poly-D/L-Lactide and Beta-Tricalcium Phosphate in a Loading Site.Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation.Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis.

P2860

Q24641909-392A3F13-DF9B-4C64-BCAD-3F1EF8E56313 Q28281007-52F982DA-3CB7-4BA7-A3E2-65DBA773D615 Q28586013-7F17D739-8EBD-4EE2-98D7-E27CD07F9AC0 Q33577294-2D68C3BC-76C8-4A02-993A-49EF084ED133 Q33715021-FA169E9B-CDC1-477B-8D97-016474CA7FE0 Q33894869-DE296C28-A8B0-4F28-9651-E18021C0EEE4 Q34249099-B77F5488-9A59-4023-B36F-71AB5B5A6EE7 Q34291256-B6648B6F-697E-4F64-83E3-C67335FE0CE2 Q34333682-ED7F4D68-6B83-4AF0-A07C-B3A69C8F809D Q34424720-D80E1383-6714-41C6-BB94-447A4705EE5A Q34479060-8566FAA3-A399-4F44-AAE0-C0D879693A25 Q34621071-F26A3EE4-AAE0-408C-BA86-35E09B9A3CED Q34773850-C407AC32-6928-47DC-B5E5-238C968B99B5 Q34774697-49196452-83D8-4231-815C-536B533B6B03 Q34898865-9ED3404E-91EC-4766-B7F6-ACEAEA04E9C6 Q34993353-B5BE4062-A3CA-498F-A7A9-070135179F9C Q35071181-BA846FB2-ADC2-4869-A3DF-83A0531028DA Q35287635-370DED1B-5385-4DF9-9BC0-1696D2411BA5 Q35603135-0EC20E9A-9C10-410F-B21B-D9B5671DF7CE Q35969297-B05F0242-F453-4112-8764-EB8108FC4CE5 Q36279545-D5A2F3B5-4554-4C6A-B796-8749B27E357F Q36616577-EFEAB93D-1B8A-4B92-B2EB-8AA9A5E301FB Q36661323-7F049EB0-968A-4BBA-B025-51CE7716CF35 Q36727361-3876218C-5C97-4F4C-BC14-D9AAF2A30F5E Q36789786-0C01A8E2-5FCC-486A-BCC0-F13B4003EC09 Q36860987-76EFB3A5-A4DA-449A-AB44-BEA7370003D7 Q36917940-757D3B50-7CDF-4AF1-ABF4-FC2FDC0F42DE Q37026949-916CDCC5-31A4-41CD-98C6-B46FC59459F7 Q37516656-7926B4BD-CFD7-4667-BA20-1C4544EC7FC4 Q37592911-24045898-BE19-4164-ADDE-9A966E352835 Q37694830-6CF7B95A-7393-4CDF-931A-D3F2E5BB6698 Q38061373-1DEB8640-C6C1-43BF-8C6E-DE65EA0D53D3 Q38204490-0ACD6F61-0765-4C1D-80F8-CC82A7D016A8 Q38332288-925DA0D0-58DF-4855-A518-B7D842AC174F Q39181420-E9AD98EE-99C2-45A7-AD47-084AA0EAA597 Q40067295-70E1D14E-3957-48EB-A17E-33EDA14BEB7B Q41174769-070755FC-D9B1-4684-97A0-7F346773F645 Q41869707-3332C64C-125B-46E6-8715-56D69058C80E Q43612618-4487CFB9-7224-46C5-AFFE-265970C390B0 Q43989185-AEBE5310-1665-4D1A-9290-190BE047C0C9

P2860

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Item

http://www.wikidata.org/entity/Q40655044

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Induction of osteoclast differ ...... x2-/- mice by RANKL transgene.

@en

type

Item

label

Induction of osteoclast differ ...... x2-/- mice by RANKL transgene.

@en

prefLabel

Induction of osteoclast differ ...... x2-/- mice by RANKL transgene.

@en

P1476

Induction of osteoclast differ ...... x2-/- mice by RANKL transgene.

@en

P2093

Akira Zanma

http://www.w3.org/2001/XMLSchema#string

Atsuko Mizuno

http://www.w3.org/2001/XMLSchema#string

Carolina A Yoshida

http://www.w3.org/2001/XMLSchema#string

Hirayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

Hisataka Yasuda

http://www.w3.org/2001/XMLSchema#string

Kanji Higashio

http://www.w3.org/2001/XMLSchema#string

Kazuki Yano

http://www.w3.org/2001/XMLSchema#string

Kazuto Hoshi

http://www.w3.org/2001/XMLSchema#string

Kenji Takada

http://www.w3.org/2001/XMLSchema#string

Naoko Kanatani

http://www.w3.org/2001/XMLSchema#string

P2860

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

RANK is essential for osteoclast and lymph node development

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

P304

23971-23977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M302457200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12697767

http://www.w3.org/2001/XMLSchema#string

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

about

P2860

P2860

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698